Sign in
4

Changes in Ownership

Summit Therapeutics Inc. Filed Acc 0001599298-23-000101

Chief Financial Officer bought 20,400 shares at an average $2.17 ($44,254)

From the SEC's structured data for this filing

Trades in this filing

Dhingra Ankur · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-12-13 Purchase : show line 1 in the form +700 $2.15 $1,505 235,258 I
2023-12-13 Purchase : show line 2 in the form +19,700 $2.17 $42,749 254,958 I
Open-market purchases · 20,400 sh · avg $2.17 · $44,254
Loading xslF345X05/wk-form4_1702504149.xml…